Daron Wells, a father of three and husband, has stage 4 lung cancer. He's now fighting his health insurance company for a ...

Daron Wells, a father of three and husband, has stage 4 lung cancer. He's now fighting his health insurance company for a ...

Helene Duhamel was recently diagnosed with non-small cell squamous cell lung cancer. Duhamel shares her thoughts on her ...

BeyondSpring Inc.’s BYSI share price has dipped by 7.30%, which has investors questioning if this is right time to buy.

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the ...

Clinical-stage biopharmaceutical venture OmRx Oncology (OmRx) has commenced a randomised Phase II clinical trial for its oral ...

Drug resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, occurring via secondary mutations or bypass pathways, is frequent among non-small-cell lung cancer patients.

A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

Predictors of longer postdiscontinuation progression-free survival include complete/partial response, longer treatment duration.

2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes ...

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had inadequate response to immune checkpoint inhibitor ...